|
1）Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999; 284(5417): 1168-70
|
|
|
|
2）Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology. 2000; 32(1): 11-6
|
|
|
|
|
3）Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology. 2008; 135(2): 438-50
|
|
|
|
|
|
4）Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl. 2010; 16(2): 118-29
|
|
|
|
|
|
5）Stutchfield BM, Forbes SJ, Wigmore SJ. Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl. 2010; 16(7): 827-36
|
|
|
|
|
|
6）Souza BS, Nogueira RC, de Oliveira SA, et al. Current status of stem cell therapy for liver diseases. Cell Transplant. 2009; 18(12): 1261-79
|
|
|
|
|
|
7）Takami T, Terai S, Sakaida I. Stem cell therapy in chronic liver disease. Curr Opin Gastroenterol. 2012; 28(3): 203-8
|
|
|
|
|
|
8）Pai M, Spalding D, Xi F, et al. Autologous bone marrow stem cells in the treatment of chronic liver disease. Int J Hepatol. 2012. [Epub 2011 Nov 3.]
|
|
|
|
|
|
9）Terai S, Sakaida I, Yamamoto N, et al. An in vivo model for minitoring the transdifferentiation of bone marrow cells into functinal hepatocytes. Journal of Biochemistry. 2003; 134(4): 551-8
|
|
|
|
|
10）Terai S, Sakaida I, Nishina H, et al. Lesson from the GFP/CCl4 model-translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis. J Hepatobiliary Pancreat Surg. 2005; 12(3): 203-7
|
|
|
|
|
|
11）Sakaida I, Terai S, Yamamoto N, et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004; 40(6): 1304-11
|
|
|
|
|
|
12）Ishikawa T, Terai S, Urata Y, et al. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes. Cell Tissue Res. 2006; 323(2): 221-31
|
|
|
|
|
|
13）Maeda M, Takami T, Terai S, et al. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis. J Gastroenterol Hepatol. 2012; 27(Suppl 2): 104-11
|
|
|
|
|
|
14）Gordon MY, Levicar N, Pai M, et al. Characte-rization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006; 24(7): 1822-30
|
|
|
|
|
|
15）Spahr L, Lambert JF, Rubbia-Brandt L, et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology. 2008; 48(1): 221-9
|
|
|
|
|
|
16）Pai M, Zacharoulis D, Milicevic MN, et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastro-enterol. 2008; 103(8): 1952-8
|
|
|
|
|
|
17）Han Y, Yan L, Han G, et al. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy. Cytotherapy. 2008; 10(4): 390-6
|
|
|
|
|
|
18）Falzetti F, Aversa F, Minelli O, et al. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet. 1999; 353(9152): 555
|
|
|
|
|
|
19）Terai S, Ishikawa T, Omori K, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006; 24(10): 2292-8
|
|
|
|
|
|
20）Terai S, Sakaida I. Current status of autologous bone marrow cell infusion therapy for liver cirrhosis patients. Hepatol Res. 2008; 38(The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan): S72-5
|
|
|
|
|
|
21）Terai S, Sakaida I. Autologous bone marrow cell infusion therapy for liver cirrhosis patients. J Hepatobiliary Pancreat Sci. 2011; 18(1): 23-25
|
|
|
|
|
|
22）Kim JK, Park YN, Kim JS, et al. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant. 2010; 19(10): 1237-46
|
|
|
|
|
|
23）Saito T, Okumoto K, Haga H, et al. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev. 2011; 20(9): 1503-10
|
|
|
|
|
|
24）Peng L, Xie DY, Lin BL, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes. Hepatology. 2011; 54(3): 820-8
|
|
|
|
|
|
25）Lyra AC, Soares MB, da Silva LF, et al. Feasibility and safety of autologous bone marrow mono-nuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol. 2007; 13(7): 1067-73
|
|
|
|
|
|
26）Lyra AC, Soares MB, da Silva LF, et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010; 22(1): 33-42
|
|
|
|
|
|
27）am Esch JS 2nd, Knoefel WT, Klein M, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005; 23(4): 463-70
|
|
|
|
|
|
28）Furst G, Schulte am Esch J, Poll LW, et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology. 2007; 243(1): 171-9
|
|
|
|
|
|
29）Mohamadnejad M, Namiri M, Bagheri M, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol. 2007; 13(24): 3359-63
|
|
|
|
|
|
30）Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007; 10(4): 459-66
|
|
|
|
|
|
31）Kharaziha P, Hellstrom PM, Noorinayer B, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009; 21(10): 1199-205
|
|
|
|
|
|
32）Amer ME, El-Sayed SZ, El-Kheir WA, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 2011; 23(10): 936-41
|
|
|
|
|